What is the recommended dosage of norfloxacin‑tinidazole (Norflox TZ) for adults, and how should the dose be adjusted in patients with severe renal impairment?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: May 11, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Norflox TZ Dosage

The standard adult dosage of Norflox TZ (norfloxacin-tinidazole combination) is norfloxacin 400 mg once or twice daily, and in patients with severe renal impairment (creatinine clearance <30 mL/min), the norfloxacin dose should be reduced to 400 mg once daily or every other day, while tinidazole requires no dose adjustment.

Standard Adult Dosing

The typical regimen for Norflox TZ in adults with normal renal function is:

  • Norfloxacin component: 400 mg once or twice daily (depending on infection severity)
  • Tinidazole component: Standard dose as per combination formulation
  • Duration varies by indication (typically 3-7 days for acute infections)

Dose Adjustment in Severe Renal Impairment

When creatinine clearance falls below 30 mL/min, dosing modifications are essential:

Norfloxacin Component

  • Reduce dose to 50% of normal: 400 mg once daily instead of twice daily 1, 2
  • Alternatively, maintain 400 mg but extend dosing interval to every 48 hours 3
  • The rationale: norfloxacin elimination half-life increases from 3-4 hours to 8+ hours in severe renal failure 2
  • Despite reduced dosing, urinary concentrations remain therapeutic even in severe renal impairment 1, 2

Tinidazole Component

  • No dose adjustment required 4
  • Tinidazole pharmacokinetics remain unchanged in severe renal failure (half-life 16-18 hours regardless of renal function)
  • No accumulation of metabolites occurs 4
  • Full dose should be given after hemodialysis if applicable 4

Clinical Considerations

Key safety point: Higher-than-recommended fluoroquinolone doses in patients with advanced chronic kidney disease (eGFR <30 mL/min/1.73 m²) significantly increase the risk of nervous system disorders, psychiatric events, hypoglycemia, and collagen-associated complications 3. The absolute risk increase is modest (0.39%) but clinically meaningful in this vulnerable population.

Monitoring Requirements

  • Assess renal function before initiating therapy
  • In elderly patients (>65 years), expect greater drug accumulation with repeated dosing, particularly when creatinine clearance is <30 mL/min 5
  • Watch for CNS effects (confusion, seizures), tendon problems, and hypoglycemia in renally impaired patients

Practical Dosing Algorithm

  1. Calculate creatinine clearance (use Cockcroft-Gault or eGFR)
  2. If CrCl ≥30 mL/min: Standard dose (400 mg norfloxacin once or twice daily)
  3. If CrCl <30 mL/min: Reduce to 400 mg norfloxacin once daily
  4. If on hemodialysis: Give 400 mg norfloxacin after dialysis session
  5. Tinidazole: No adjustment needed at any level of renal function

The combination's effectiveness is preserved even with dose reduction because adequate urinary antimicrobial concentrations are maintained 1, 2, while systemic accumulation and toxicity risk are minimized 3.

Related Questions

Can sucralfate be used in chronic kidney disease, and what dosing adjustments are recommended for different levels of renal impairment?
What is the recommended dosing of sultamicillin 750 mg for adult infections, including adjustments for renal impairment?
How harmful is cyclobenzaprine (Flexeril) to the kidneys, and what alternative muscle relaxants are safe in renal impairment?
Is lacosamide nephrotoxic, and what dosing adjustments are required for patients with impaired renal function?
What is the recommended dosing of tolperisone for adults with chronic kidney disease, including adjustments for varying levels of renal impairment?
What did the LUNG SAFE (Large Observational Study to Understand the Global Epidemiology of Severe Acute Respiratory Failure) study find regarding ARDS incidence, recognition, mortality, and what are the recommended evidence‑based management measures?
What is the difference between a lung volume and a lung capacity?
How can mild ascites lead to a massive pleural effusion?
In an older adult with dementia who stays awake at night and experiences nighttime falls, currently taking nightly olanzapine 10 mg and tamsulosin 0.4 mg, with stable vital signs and bilateral lower‑extremity edema being treated with ceftriaxone (Rocephin) 1 g twice daily, and whose falls began before the infection, what are the likely contributors to the falls and how should the medication regimen be adjusted to reduce fall risk?
How is the ProVent risk score calculated for a patient on invasive mechanical ventilation for more than 21 days, and how does the resulting score guide prognosis and management?
How should anticoagulation be managed in a post‑craniotomy patient with an INR of 3 who is taking warfarin 5 mg daily?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.